Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

NCT06155331 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Stage 2 and 3

Interventions

DRUG: Fenofibrate
OTHER: Placebo
DRUG: Doxorubicin
DRUG: Cyclophosphamide

Sponsor

Tanta University